Cure Alzheimer's Fund Cure Alzheimer's Fund

Nanobodies to Cross the Blood-Brain Barrier

2016, 2017

The blood-brain barrier (BBB) is a vital barrier between the bloodstream and the brain. This barrier tightly controls which molecules can enter the brain. As a consequence of this barrier, the majority of currently available drugs can’t enter the brain. Importantly, to treat Alzheimer’s disease, drugs need to reach the brain. The aim of this project is to generate a universal tool that can transport drug molecules to the brain.

Bart De Strooper Drug Delivery and Design Drug Discovery Maarten Dewilde

Funding to Date

$300,000

Focus

Drug Delivery and Design, Drug Discovery

Researchers

Bart De Strooper, M.D., Ph.D.

Maarten Dewilde, Ph.D.

Related Content:


Identifying Mediators of Tau-Mediated Neuronal Necroptosis Using an Innovative In Vivo CRISPR Screen Bart De Strooper Sriram Balusu 2023-12-08 Novel Entry Routes for Therapeutic Biologicals to the Brain Maarten Dewilde Bart De Strooper 2020-12-18 The Effect of Chronic Gamma-Secretase Modulation on the Prevention of Traumatic Brain Injury-Provoked and Alzheimer’s Disease-Relevant Biochemical, Pathological and Behavioral Alterations Steven L. Wagner Brian P. Head 2018-12-24 Evaluation of Blood-Brain Barrier (BBB) Penetration of Alzheimer’s Drug Targets, and Identification of BBB Integrity Enhancers Roger D. Kamm Se Hoon Choi 2018-08-09 Imaging Microglial Homeostasis and Disruption: P2RY12 Radiotracer Development Jacob Hooker Michael Placzek 2018-07-24 Nanobodies to Cross the Blood-Brain Barrier Bart De Strooper Maarten Dewilde 2016-09-01 Optimization of Pharmacalogic Properties of Molecular Tweezers Gal Bitan 2015-06-25 Mechanisms of Retinoid X Receptor-Mediated Abeta Clearance in Alzheimers’ Disease David Holtzman Gary Landreth 2011-11-11